{"id":603,"date":"2019-03-02T08:08:04","date_gmt":"2019-03-02T08:08:04","guid":{"rendered":"https:\/\/ninetheme.com\/themes\/lumire\/?page_id=603"},"modified":"2020-05-27T16:35:50","modified_gmt":"2020-05-27T16:35:50","slug":"readmission-risk-assessments","status":"publish","type":"page","link":"https:\/\/www.avixena.com\/avwp\/readmission-risk-assessments\/","title":{"rendered":"Readmission Risk Assessment Tools"},"content":{"rendered":"

[vc_row full_width=”stretch” lumire_row_prepad=”section-sm” css=”.vc_custom_1574461152935{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}”][vc_column offset=”vc_col-xs-12″][vc_custom_heading text=”Readmission Risk Assessment Tools”][vc_empty_space][vc_custom_heading lumire_heading=”heading” text=”The Revolving Door Problem of Hospital Readmissions” htag=”h3″ heading_fw=”semi-bold”][vc_column_text]Reducing hospital readmission rates has become a priority to policymakers as readmissions are common, costly and, at least in theory, a reasonable fraction of them should be preventable. Policymakers therefore believe that reducing readmission rates represents a unique opportunity simultaneously to improve quality of care and reduce costs. As part of the Affordable Care Act (ACA), Congress directed the Centers for Medicare and Medicaid Services (CMS) to penalize hospitals with “worse than expected” 30-day readmission rates. This part of the ACA has motivated hospitals, health systems, professional societies and independent organizations to invest substantial resources into finding and implementing solutions for the “readmissions problem”.<\/p>\n

 <\/p>\n

avixena provides unique Readmission Risk Assessment Survey tools which were developed after reviewing more than 60,000 inpatient Medicare FFS, Medicare Advantage, D-SNP, and Managed Medicaid admissions.[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=”stretch” lumire_row_prepad=”section-sm” css=”.vc_custom_1574461190492{margin-top: 0px !important;}”][vc_column offset=”vc_col-xs-12″]

<\/div>[vc_empty_space][vc_custom_heading lumire_heading=”heading” text=”The average cost of a single readmission to a hospital” htag=”h3″ heading_fw=”semi-bold” heading_clr=”custom” def_align=”text-center” md_align=”md-center” sm_align=”sm-center” xs_align=”xs-center” lumire_fw=”fw-600″ lemure_ch_default_css_desc=”” res_sm_fs=”27px” lumire_bclr=”#94c727″ custom_clr=”#dd3333″][\/vc_column][\/vc_row][vc_row full_width=”stretch” lumire_row_prepad=”section-sm” css=”.vc_custom_1574697046951{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}”][vc_column width=”1\/2″ offset=”vc_col-xs-12″][vc_icon icon_fontawesome=”fa fa-usd” color=”peacoc” align=”right” css=”.vc_custom_1575311529331{margin-right: 0px !important;border-right-width: 0px !important;border-left-width: 0px !important;padding-right: 0px !important;padding-left: 0px !important;}”][\/vc_column][vc_column width=”1\/2″]

13,000<\/h3> <\/span><\/div>[\/vc_column][\/vc_row][vc_row full_width=”stretch” lumire_row_prepad=”section-sm” css=”.vc_custom_1574461222149{margin-top: 0px !important;border-top-width: 0px !important;padding-top: 0px !important;}”][vc_column offset=”vc_col-xs-12″][vc_column_text]The scoring methodology and analysis was based on a review of 7,000 readmissions, resulting in a scoring system allowing for automatic generation of options, such as a discharge plan. avixena apps are the most advanced assessment tool in their class with >90% specificity and >90% sensitivity. These tools incorporate and quantify the effect on readmission of Social Determinants of Health<\/strong> \u2013 availability of transportation, housing, social support system, and insurance.[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=”stretch” lumire_row_overlay_type=”background-shape-3″ css=”.vc_custom_1552543874636{background-color: #fafafa !important;}”][vc_column offset=”vc_col-md-offset-2 vc_col-md-8 vc_col-xs-12″][vc_custom_heading lumire_heading=”heading” text=”READMISSION RISK ASSESSMENT TOOLS” htag=”h3″ heading_fw=”semi-bold” def_align=”text-center” lumire_fw=”fw-600″ lemure_ch_default_css_desc=”” res_sm_fs=”27px” lumire_bclr=”#94c727″][vc_separator lumire_separator_align=”center”][\/vc_column][vc_column css=”.vc_custom_1552542928244{margin-bottom: -25px !important;}”][vc_row_inner lumire_premartop=”mt-30″][vc_column_inner offset=”vc_col-lg-4 vc_col-md-6 vc_col-xs-12″]
<\/i><\/div>

General Readmission Risk Assessment Survey Tool<\/h4>

The most advanced assessment tool in its class. Designed to identify patient's readmission risk status, has a scoring system, and allows for generation of options, such as a discharge plan.<\/p><\/div>[\/vc_column_inner][vc_column_inner offset=”vc_col-lg-4 vc_col-md-6 vc_col-xs-12″]

<\/i><\/div>

Readmission Root Cause Assessment Tool<\/h4>

Designed to assess root causes and contributing factors that have resulted in readmissions and automatically creates an action plan to mitigate and manage the identified issues.<\/p><\/div>[\/vc_column_inner][vc_column_inner offset=”vc_col-lg-4 vc_col-md-6 vc_col-xs-12″]

<\/i><\/div>

Extended Care Facility Transfer Readmission Risk Assessment Tool<\/h4>

Designed to alert and assist extended care facilities with managing moderate and high-risk patients prior to transfer from the acute care setting. The same methodology was used to develop and validate its effectiveness as was used for the RAS Tools.<\/p><\/div>[\/vc_column_inner][\/vc_row_inner][vc_row_inner lumire_premartop=”mt-30″][vc_column_inner width=”1\/2″]

<\/i><\/div>

Pediatric Readmission Tool<\/h4>

Has all the features described in the Adult RAS Tool but also incorporates and quantifies the effect of issues limited to pediatric population on read- missions (i.e., impact of pre-term birth, genetic conditions, immunization status, impairment of growth and development, and caregiver\u2019s mental health status). The Pediatric RAS Tool was developed based on Dr. Shafa\u2019s experience with two of the largest Pediatric-only managed care organizations in the US.<\/p><\/div>[\/vc_column_inner][vc_column_inner width=”1\/2″]

<\/i><\/div>

Behavioral Health Readmission Tool<\/h4>

The Behavioral Health RAS Tool has all the features described in the RAS Tool and is the only tool of its kind that identifies and incorporates the impact of age, previously diagnosed behavioral health conditions, and discharge destination on readmissions.<\/p><\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row full_width=”stretch” css=”.vc_custom_1574207706207{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}”][vc_column width=”1\/2″][vc_btn title=”Read our Readmissions White Paper” color=”primary” align=”center” link=”url:https%3A%2F%2Fwww.avixena.com%2Favwp%2Fwp-content%2Fuploads%2F2020%2F05%2Favixena-readmission-White-Paper-5-21-2020.pdf|||”][\/vc_column][vc_column width=”1\/2″][vc_btn title=”Download Our Brochure” color=”primary” align=”center” link=”url:https%3A%2F%2Fwebsite.avixena.com%2Favwp%2Fwp-content%2Fuploads%2F2019%2F10%2Favixenabrochure032019.pdf|||”][\/vc_column][\/vc_row][vc_row full_width=”stretch” css=”.vc_custom_1574371090545{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}”][vc_column][vc_cta h2=”For more information contact avixena.” add_button=”right” btn_title=”Contact Us” btn_color=”primary” btn_link=”url:https%3A%2F%2Fwebsite.avixena.com%2Favwp%2Fcontact-us%2F|||” css=”.vc_custom_1574371469709{margin-top: 0px !important;border-top-width: 0px !important;padding-top: 0px !important;}”][\/vc_cta][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1574371100690{margin-top: 0px !important;border-top-width: 0px !important;padding-top: 0px !important;}”][vc_column][vc_raw_html el_id=”footer” el_class=”ftext”]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[\/vc_raw_html][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row full_width=”stretch” lumire_row_prepad=”section-sm” css=”.vc_custom_1574461152935{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 0px !important;}”][vc_column offset=”vc_col-xs-12″][vc_custom_heading text=”Readmission Risk Assessment Tools”][vc_empty_space][vc_custom_heading lumire_heading=”heading” text=”The Revolving Door Problem of Hospital Readmissions” htag=”h3″ heading_fw=”semi-bold”][vc_column_text]Reducing hospital readmission rates has become a priority to policymakers as readmissions are common, costly and, at least in theory, a reasonable fraction of them should be preventable. Policymakers therefore believe…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"custom-page.php","meta":{"footnotes":""},"class_list":{"0":"post-603","1":"page","2":"type-page","3":"status-publish","4":"hentry","5":"","8":" nt-post-class "},"_links":{"self":[{"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/pages\/603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/comments?post=603"}],"version-history":[{"count":50,"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/pages\/603\/revisions"}],"predecessor-version":[{"id":2139,"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/pages\/603\/revisions\/2139"}],"wp:attachment":[{"href":"https:\/\/www.avixena.com\/avwp\/wp-json\/wp\/v2\/media?parent=603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}